Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer
Abstract:
Although non-melanoma skin cancer (NMSC) is the most common human cancer and its incidence continues to rise worldwide, the mechanisms underlying its development remain incompletely understood. Here, we unveil a cascade of events involving peroxisome proliferator-activated receptor (PPAR) β/δ and the oncogene Src, which promotes the development of ultraviolet (UV)-induced skin cancer in mice. UV-induced PPARβ/δ activity, which directly stimulated Src expression, increased Src kinase activity and enhanced the EGFR/Erk1/2 signalling pathway, resulting in increased epithelial-to-mesenchymal transition (EMT) marker expression. Consistent with these observations, PPARβ/δ-null mice developed fewer and smaller skin tumours, and a PPARβ/δ antagonist prevented UV-dependent Src stimulation. Furthermore, the expression of PPARβ/δ positively correlated with the expression of SRC and EMT markers in human skin squamous cell carcinoma (SCC), and critically, linear models applied to several human epithelial cancers revealed an interaction between PPARβ/δ and SRC and TGFβ1 transcriptional levels. Taken together, these observations motivate the future evaluation of PPARβ/δ modulators to attenuate the development of several epithelial cancers.
Insights
Researchers discovered a pathway involving peroxisome proliferator-activated receptor (PPAR) β/δ and the Src oncogene in UV-induced skin cancer. Targeting PPARβ/δ may offer new strategies for treating epithelial cancers.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Non-melanoma skin cancer (NMSC) is the most common human cancer with rising global incidence.
- Mechanisms driving NMSC development are not fully understood.
- Ultraviolet (UV) radiation is a primary risk factor for skin cancer.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying UV-induced skin cancer development.
- To investigate the role of peroxisome proliferator-activated receptor (PPAR) β/δ and the Src oncogene in skin carcinogenesis.
- To explore potential therapeutic targets for epithelial cancers.
Main Methods:
- Utilized mouse models of UV-induced skin cancer.
- Investigated the activity of PPARβ/δ and Src signaling pathways.
- Assessed epithelial-to-mesenchymal transition (EMT) markers.
- Examined human skin squamous cell carcinoma (SCC) and other epithelial cancers.
- Employed linear models to analyze gene expression interactions.
Main Results:
- UV exposure activates PPARβ/δ, which directly upregulates Src expression and kinase activity.
- Activated Src enhances the EGFR/Erk1/2 pathway, promoting EMT marker expression.
- PPARβ/δ-deficient mice exhibited reduced skin tumor formation.
- A PPARβ/δ antagonist inhibited UV-dependent Src activation.
- PPARβ/δ expression positively correlated with SRC and EMT markers in human SCC.
- Identified an interaction between PPARβ/δ, SRC, and TGFβ1 in human epithelial cancers.
Conclusions:
- A signaling cascade involving UV-induced PPARβ/δ and Src promotes skin cancer development.
- PPARβ/δ plays a critical role in UV carcinogenesis and EMT.
- Findings suggest PPARβ/δ modulators as potential therapeutic agents for various epithelial cancers.
- The identified pathway highlights a potential therapeutic strategy for NMSC and other epithelial malignancies.
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:


